Skip to content
Governance Register

Company

DE Novo Pharmaceuticals Limited

Official record Companies House · updated 4th October 2026 · Sources

Network

The large node is DE Novo Pharmaceuticals Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 20

  1. Mark Rowland Clement 2008-2014 Director View profile
  2. Dr Brian Adger 2007-2013 Director View profile
  3. Marcus Antonius Wegter 2007-2008 Director View profile
  4. Salvatore D'Orsa 2005-2008 Director View profile
  5. Andrew John Allars 2005-2006 Director View profile
  6. Alun Huw Jones 2004-2006 Director View profile
  7. Bart Wuurman 2003-2005 Director View profile
  8. Dr Steven Colin Beasley 2001-2004 Director View profile
  9. Frederik Vincent Van Der Have 2001-2005 Director View profile
  10. Dr Susan Elizabeth Foden 2001-2003 Director View profile
  11. Dr Barry Porter 2001-2001 Director View profile
  12. Dr Michael John Ashton 2000-2005 Director View profile
  13. Dr Christopher Alan Keightley 2000-2001 Director View profile
  14. Alan Gilbert Goodman 2000-2004 Director View profile
  15. Dr Robert Ian James 2000-2007 Director View profile
  16. Dr Philip Michael Dean 1999-2008 Director View profile
  17. Abbey Directors Limited 1999-1999 Corporate-director View profile
  18. Anthony John Bunn 2000-2024 Secretary View profile
  19. Dr David Stanley Bailey 1999-2002 Secretary View profile
  20. Abbey Nominees Limited 1999-1999 Corporate-secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

Incorporated
28/04/1999

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

  • Farhad Fahid
    25-50% shares, 25-50% voting · notified 2023-05-12

Group

  1. DE Novo Pharmaceuticals Limited is controlled by Farhad Fahid
    Evidence
    active 25-50% shares, 25-50% voting · notified 2023-05-12 · source: Companies House PSC register

Ultimately controlled by Farhad Fahid.

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Financials

Net assets
£21,365
Total assets
£51,990
Employees
2
Turnover
Not reported (small or micro-entity accounts)

Filed as Micro-entity accounts.

Figures from accounts filed at Companies House (iXBRL), period ending 2025-09-30. Where turnover is absent, small and micro-entity accounts are not required to report it, so it is not shown as zero.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

2 directors on the board

11.4y median 11.4y
average tenure
11.7y
longest tenure

Directors past 6 years

First-time vs portfolio directors

Portfolio (2)

0
also govern a charity
0
left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Arts and leisure 1Professional services 1

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Gaps to watch

  • Several long-serving directors could step down together

Where to look Suggested search: succession planning for long-tenured seats.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
03761178
Status
Active
Type
Private Limited Company
Edition
Register edition compiled 4th October 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data